D2L Pharma Research Solutions Private Limited - Company overview

D2L Pharma Research Solutions is an active private limited company registered with ROC Hyderabad on 6 July 2007, about 19 years ago.

2007-07-06 Hyderabad, Telangana Active Unlisted Active Compliant
Connect MCP

Key Metrics Public MCA facts are exact. Revenue, profit, assets, and employee figures may show as ranges until unlocked.

REVENUE
₹5–10 Cr
▼ -3.1%
FY 2023
PROFIT / LOSS
₹10–50 Lakh
▼ -36.5%
FY 2023
EBITDA
₹10–50 Lakh
▼ -77.5%
FY 2023
NET WORTH
₹5–10 Cr
▲ 4.7%
FY 2023
TOTAL ASSETS
₹5–10 Cr
▲ 10.4%
FY 2023
EMPLOYEE COUNT
41–50
OPEN CHARGES
1
2.60 cr
PAID-UP CAPITAL
28.78 Lakh
AUTHORISED CAPITAL
50.00 Lakh
COMPANY AGE
19 Years 3 Months
since 2007-07-06
LAST FILING WITH ROC
2025-03-31
Last AGM: 2025-09-30
ACTIVE GST
1
Updated: 2025-05-30 11:53:57
TOTAL MONEY RAISED
₹10–50 Lakh
SATISFIED CHARGES
1
-

Company Health Scores Scores from 0–100 based on filings, compliance signals, financials, and board history on this profile.

Health scores for D2L Pharma Research Solutions covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.

Vendor Trust Score Low risk
91/100
Overall counterparty comfort for vendors and customers.
  • Blend of compliance (88), financial health (90), director (95) and company-foundation signals.
  • Operating for 19+ years.
Compliance Score Low risk
88/100
Statutory filings, status and regulatory flags.
  • Company status is Active as per MCA.
  • Last balance sheet filed for Mar 2025 - slightly behind.
Financial Health Score Low risk
90/100
Profitability, leverage and liquidity from filed statements.
  • Profitable in FY 2023.
  • Positive net worth.
Director Risk Score Low risk
95/100
Board strength, DIN status and churn.
  • 4 directors on the board.
  • No disqualified or deactivated DINs on the current board.
Scores are derived from MCA filings, financial statements and public records on this page. Higher is safer. They are indicative, not a credit rating.
360° Intelligence Report: trust score, financial health, credit risk, growth & distress signals - auto-generated from filings. View report →

About D2L Pharma Research Solutions Company identity, industry, contact, and registration details from MCA and company records.

D2L Pharma Research Solutions is an active private limited company registered with ROC Hyderabad on 6 July 2007, about 19 years ago. The registered office is at H.No: 16-11-16/75, Plot No.75 Sripuram Colony, Malakpet, Hyderabad, Telangana.

In its MCA filings the main business is listed as management consultancy activities, which made up 100% of turnover.

It has four directors: Marella Ravikant, Shekhar Gupta, Kode Sashi Kiran and Sudheesh Kookkal. The longest-serving is Kode Sashi Kiran, on the board since 2007; the most recent to join is Sudheesh Kookkal, appointed in October 2025. Kode Sashi Kiran is the managing director. Two former directors are on record; the most recent to leave was Ratna Kumari Kode in October 2012. Between them, the directors also sit on the boards of 8 other companies, including D2l Academia Of Excellence Private Limited and Om Sai Gururaja Foods Private Limited.

₹28.78 lakh of its ₹50 lakh authorised capital is paid up (about 58%). Its latest balance sheet on MCA is for the year ending 31 March 2025, and the last AGM was on 30 September 2025. The one charge registered against it has been satisfied, so no secured loan is open.

Life Sciences ••••••••
  • Location H.No: 16-11-16/75, Plot No.75 Sripuram Colony, Malakpet, Hyderabad, Telangana - 500036
  • Website d2lpharma.com
LinkedIn Facebook Twitter
Legal NameD2L Pharma Research Solutions Private Limited
CIN / LLPINU24232TG2007PTC054728
Company No.054728
ClassificationPrivate Limited Indian Non-Government Company
Incorporation Date2007-07-06
Date of AGM2025-09-30
Date of Balance Sheet2025-03-31
Listing StatusUnlisted
ROC CodeRoc Hyderabad
PAN
LEI Number
Active ComplianceActive Compliant

Current Directors of D2L Pharma Research Solutions (4) Current board members from MCA filings, including designation and appointment details.

M
Marella Ravikant
Whole-time director | Since 2010-02-05 | DIN: 02699241
S
Shekhar Gupta
Whole-time director | Since 2008-01-18 | DIN: 02101816
K
Kode Sashi Kiran
Managing Director | Since 2007-07-06 | DIN: 01562875
S
Sudheesh Kookkal
Additional Director | Since 2025-10-27 | DIN: 11354958

Financial Performance of D2L Pharma Research Solutions Bands and Low / Medium / High trend shape. Exact figures unlock with your report.

Estimated bands · FY 2023
Revenue ₹5–10 Cr ▼ -3.1%
P&L ₹10–50 Lakh ▼ -36.5%
EBITDA ₹10–50 Lakh ▼ -77.5%
Net worth ₹5–10 Cr ▲ 4.7%

Exact figures and labelled charts require an active report plan.

Verified entity values are shown only after access is granted.

Charges of D2L Pharma Research Solutions Open and satisfied charges registered against the company with MCA.

Others : 2.60 cr
Open Charges: 1 Satisfied Charges: 1
Open 2.60 cr
Satisfied 0
LenderAmountStatus
Others
Creation Date: 30 Apr 2020
 2.60 cr Closed

Business Activity Principal business activity and turnover mix from MCA filings.

Activity GroupDescriptionTurnover %
Professional, Scientific and TechnicalManagement consultancy activities100

Companies With Common Directors Of D2l Pharma Research Solutions Other companies that share directors with this entity, based on MCA and compliance network data.

Board Overlap From MCA / Compliance Filings

D2l Academia Of Excellence Private Limited 3 Shared Directors
Om Sai Gururaja Foods Private Limited 2 Shared Directors
Alx Biotech Private Limited 1 Shared Director
Arunachalamm Renewable Energy Private Limited 1 Shared Director
D2l Clinical Solutions Private Limited 1 Shared Director
N9 Pharmaceuticals Private Limited 1 Shared Director
Spin And Dry Laundry Services Llp 1 Shared Director
Yobiz Healthcare Solutions Private Limited 1 Shared Director

Financial Ratios of D2L Pharma Research Solutions Profitability, leverage, and liquidity ratios from filed statements. Exact values unlock with your report.

9 years of ratios on record

Profitability, leverage and liquidity ratios require an active report plan.

Net profit margin Debt / Equity Current ratio ROE

Unlock exact ratio values and multi-year insights.

Verified entity values are shown only after access is granted.

Shareholding Pattern of D2L Pharma Research Solutions Ownership and contribution detail from filings. Full breakdown unlocks with your report.

8 shareholder categories on record

Ownership mix and contribution history require an active report plan.

Ownership mix Category breakdown Year-wise pattern Promoter holding

Unlock full ownership and contribution details.

Verified entity values are shown only after access is granted.

Employees and EPFO Compliance at D2L Pharma Research Solutions EPFO establishments, contributions, and headcount history. Full records unlock with your report.

1 establishment linked

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

Monthly headcount PF contributions ECR filing status Establishment history

Employee and EPFO history require an active report plan.

Verified entity values are shown only after access is granted.

GST Compliance of D2L Pharma Research Solutions GST registrations and filing status by state. Full compliance detail unlocks with your report.

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

GSTIN registrations State-wise filing status HSN and SAC details Tax jurisdiction records

GST registrations and filing compliance require an active report plan.

Verified entity values are shown only after access is granted.

MSME Payment Delays by D2L Pharma Research Solutions MSME supplier payment delays and filing history. Full amounts unlock with your report.

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

Outstanding amounts Delay periods and reasons MSME-1 filing history Vendor payment signals

MSME payment history requires an active report plan.

Verified entity values are shown only after access is granted.

MCA Filings & Documents of D2L Pharma Research Solutions Official MCA forms, returns, and filing index. Document access unlocks with your report.

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

Incorporation documents Annual returns and statements Charge filings Complete filing index

MCA filings and documents require an active report plan.

Verified entity values are shown only after access is granted.

Frequently Asked Questions about D2L Pharma Research Solutions Common questions about this company from MCA and profile data. Some answers are limited until unlocked.
Who is the owner of D2L Pharma Research Solutions?
MCA does not publish an "owner" field. D2L Pharma Research Solutions is run by its directors, Marella Ravikant, Shekhar Gupta, Kode Sashi Kiran and one other, with Kode Sashi Kiran as managing director. The people who own the shares are listed in its annual return (form MGT-7), which can differ from the directors.
Who are the current board members and directors of D2L Pharma Research Solutions?
D2L Pharma Research Solutions has four current directors: Marella Ravikant (since February 2010), Shekhar Gupta (since January 2008), Kode Sashi Kiran (since July 2007) and Sudheesh Kookkal (since October 2025). Kode Sashi Kiran is the managing director.
What is CIN of D2L Pharma Research Solutions?
The CIN of D2L Pharma Research Solutions is U24232TG2007PTC054728. Reading it left to right: U means it is not listed, 24232 is the industry code it registered under, TG is Telangana, 2007 is the year it was registered, PTC is the company type and 054728 is its registration number.
When was D2L Pharma Research Solutions incorporated?
D2L Pharma Research Solutions was incorporated on 6 July 2007 with ROC Hyderabad. That makes it about 19 years old.
What is the registered address of D2L Pharma Research Solutions?
The registered office on MCA records is H.No: 16-11-16/75, Plot No.75 Sripuram Colony, Malakpet, Hyderabad, Telangana - 500036.
What is the current status of D2L Pharma Research Solutions?
MCA shows D2L Pharma Research Solutions as Active, and its last AGM on record was in September 2025.
What is the contact number or email for D2L Pharma Research Solutions?
You can post to its registered office at H.No: 16-11-16/75, Plot No.75 Sripuram Colony, Malakpet, Hyderabad, Telangana - 500036 and use its website, https://d2lpharma.com.
What industry or business activity is D2L Pharma Research Solutions associated with?
Its MCA filings list the main business as management consultancy activities (100% of turnover).
What is paid-up capital and authorised share capital of D2L Pharma Research Solutions?
Paid-up capital is ₹28.78 lakh and authorised capital is ₹50 lakh, so about 58% of the authorised amount has been issued.
When did D2L Pharma Research Solutions last file accounts and hold an AGM?
The last AGM on record was on 30 September 2025, and the latest balance sheet is for the year ending 31 March 2025.
Where can I see charges and lenders for D2L Pharma Research Solutions?
No charge is open. The one charge registered against D2L Pharma Research Solutions has been satisfied.
Have any directors left D2L Pharma Research Solutions?
Yes, two former directors are on record. The most recent to leave were Ratna Kumari Kode (October 2012) and Deepak Harikrishnan (April 2012).
Which companies share directors with D2L Pharma Research Solutions?
8 companies share directors with D2L Pharma Research Solutions. Among them are D2l Academia Of Excellence Private Limited, Om Sai Gururaja Foods Private Limited, Alx Biotech Private Limited and 5 more.
What is the turnover or revenue of D2L Pharma Research Solutions?
Based on filed financial statements, the revenue of D2L Pharma Research Solutions for FY 2023 was in the ₹5–10 Cr range. That is down 3.1% on the previous year. Exact year-wise revenue, profit and balance sheet figures are on the Financial tab.
What is the net worth of D2L Pharma Research Solutions?
For FY 2023, the net worth of D2L Pharma Research Solutions was in the ₹5–10 Cr range.
How can I get the financial details of D2L Pharma Research Solutions?
The latest accounts on record are for FY 2023. The Financial tab has year-wise profit and loss, balance sheet and ratios, with exact figures after you sign in.
What is the official website of D2L Pharma Research Solutions?
The website on record for D2L Pharma Research Solutions is https://d2lpharma.com.
Which company owns d2lpharma.com?
d2lpharma.com is the website listed for D2l Pharma Research Solutions Private Limited in its company records.
D2L Pharma Research Solutions - is it listed or unlisted?
D2L Pharma Research Solutions is unlisted, so its shares are not traded on a stock exchange. Its CIN starts with U for the same reason.
What is the ROC code of D2L Pharma Research Solutions?
D2L Pharma Research Solutions is registered with ROC Hyderabad.
What is the company classification of D2L Pharma Research Solutions?
MCA classifies D2L Pharma Research Solutions as: Private Limited Indian Non-Government Company.
Does D2L Pharma Research Solutions have GST registrations on file?
Yes, one active GST registration is linked to D2L Pharma Research Solutions.

Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.